EN6 HIBO Mifamurtide TFA acts as a

Mifamurtide TFA acts as a nonspecific immunomodulator by activating macrophages and monocytes related to the upregulation of tumoricidal activity and secretion of pro-inflammatory cytokines including tumor necrosis factor (TNF)-a

but shows no obvious effect on inositol phosphate-1 formation induced by BK (3 nM) activation of B2 receptor in human fibroblast MRC5

Pyridoxal hydrochloride is an endogenous metabolite

The anti-proliferative effects are only observed at high concentrations of KA2507 hydrochloride

EN6 HIBO Mifamurtide TFA acts as aEN6 is a small molecule in vivo activator of autophagy that covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal the vacuolar H+ ATPase (v ATPase). EN6 mediated ATP6V1A modification decouples the v ATPase from the Rags, leading to inhibition of mTORC1 signaling, increased lysosomal acidification and activation of autophagy. EN6 clears TDP 43 aggregates, a causative agent in frontotemporal dementia, in a lysosome dependent manner.